Insider Transactions in Q3 2025 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2025
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
5,592
-2.0%
|
$11,184
$2.6 P/Share
|
|
Sep 03
2025
|
Amy Parison SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
458
-2.72%
|
$916
$2.6 P/Share
|
|
Sep 03
2025
|
Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
710
-1.01%
|
$1,420
$2.6 P/Share
|
|
Aug 07
2025
|
Amy Parison SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
679
-3.88%
|
$1,358
$2.58 P/Share
|
|
Jul 31
2025
|
Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,121
-7.37%
|
$10,242
$2.49 P/Share
|